Extensions

Term Details and Projected Expiration for U.S. Patent 8,267,537

As a senior U.S. patent analyst, I have reviewed the official records for U.S. Patent 8,267,537. The following details pertain to its term, related applications, and projected expiration date.

Patent Term Adjustments (PTA) and Extensions (PTE)

U.S. Patent 8,267,537 has a Patent Term Adjustment (PTA) of 328 days. This adjustment was granted by the USPTO to compensate for administrative delays that occurred during the prosecution of the patent application. The patent is not subject to any Patent Term Extension (PTE) under 35 U.S.C. § 156, which typically applies to delays in regulatory review for products like pharmaceuticals.

Continuity Data: Divisional and Continuation Applications

There is no record of any divisional or continuation applications filed that claim priority to U.S. Patent 8,267,537. The application that resulted in this patent, U.S. Application No. 12/521,490, was a national stage entry of an international patent application.

Patent Family Members

This patent is part of a larger international patent family. Key related family members include:

• International (PCT) Application: WO2008082112A1
• Korean Priority Application: KR1020060138965A
• European Patent: EP2102703B1
• Chinese Patent Application: CN101573655A
• Japanese Patent Application: JP2010515220A

Projected Expiration Date

The original expiration date for a U.S. patent filed in 2007 would typically be 20 years from the earliest non-provisional filing date. Based on its international filing date of December 21, 2007, the patent's original expiration would have been December 21, 2027.

However, with the addition of the 328-day PTA, the projected expiration date of U.S. Patent 8,267,537 is November 17, 2028. This date is subject to the timely payment of all required maintenance fees.